Agenus Receives Marketion Authorization From Armenia For Botvymo To Treat Adult Patients With Microsatellite Stable Metastatic Colorectal Cancer

Agenus Inc. has received marketing authorization from the Ministry of Health of Armenia for its drugs Botvymo (botensilimab) and Evamplix (balstilimab) to treat adult patients with microsatellite stable metastatic colorectal cancer. This marks the first marketing authorization for both medicines globally. The approvals are anticipated to benefit both local patients and those traveling to Armenia for treatment.